NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

梅毒 - 全球臨床試驗檢討:2021年前半期

Syphilis - Global Clinical Trials Review, H1, 2021

出版商 GlobalData 商品編碼 1008195
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
梅毒 - 全球臨床試驗檢討:2021年前半期 Syphilis - Global Clinical Trials Review, H1, 2021
出版日期: 2021年05月18日內容資訊: 英文 74 Pages
簡介

本報告提供全球梅毒的臨床試驗調查分析,提供臨床試驗方案概要,臨床實驗數,平均登記數,加上全球臨床實驗形勢,主要資料,主要企業等相關的系統性資訊。

目錄

目錄

  • 報告指南
  • 調查範圍
  • 臨床試驗:各地區
  • 臨床實驗數和平均登記數:各國
  • 亞太地區推動臨床試驗的前五名國家
  • 歐洲推動臨床試驗的前五名國家
  • 北美推動臨床試驗的前幾名國家
  • 中東·非洲推動臨床試驗的前五名國家
  • 中南美推動臨床試驗的前幾名國家
  • 臨床試驗:G7各國 - 感染疾病的臨床試驗上梅毒的比例
  • 臨床試驗:G7各國的不同階段
  • G7各國的臨床試驗:各臨床實驗狀態
  • 臨床試驗:E7各國 - 感染疾病的臨床試驗上梅毒的比例
  • 臨床試驗:E7各國的不同階段
  • E7各國的臨床試驗:各臨床實驗狀態
  • 臨床試驗:不同階段
  • 進行中的臨床實驗:不同階段
  • 臨床試驗:各臨床實驗狀態
  • 臨床試驗:各評估項目狀態
  • 一定期間所募集的受驗人數
  • 臨床試驗:各贊助商類型
  • 有力的贊助商
  • 參加梅毒治療臨床試驗的主要企業
  • 有力的醫藥品
  • 臨床試驗簡介的概述

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC6675CTIDB

GlobalData's clinical trial report, "Syphilis - Global Clinical Trials Review, H1, 2021" provides an overview of Syphilis Clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Syphilis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Syphilis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Syphilis Therapeutics, Global, Clinical Trials by Region, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, Central and South America, Top Countries, 2021*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Syphilis Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Syphilis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Syphilis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Syphilis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Syphilis Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Syphilis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, G7 Countries (%), 2021*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Syphilis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Syphilis to Infectious Disease Clinical Trials, E7 Countries (%), 2021*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Syphilis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Syphilis Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Syphilis Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Syphilis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Syphilis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology